| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lipoproteins |
From the Divisions of Endocrinology, Clinical Nutrition, and Vascular Medicine (A.E.M., J.C.R.), University of California, Davis, and the Departments of Medicine and Pediatrics (R.J.D., I.J.G., M.A.-H.), Columbia University College of Physicians and Surgeons, New York, NY.
Correspondence to Adam E. Mullick, TB 172, One Shields Drive, University of California, Davis, CA 95616. E-mail aemullick{at}ucdavis.edu
Abstract
Objective Liver-derived apolipoprotein E (apoE) decreases atherosclerosis without altering the circulating concentrations of plasma lipoproteins. We evaluated the effects of apoE and lipoprotein lipase (LpL) on the interactions of triglyceride-rich particles (TGRPs) in the arterial wall.
Methods and Results Quantitative fluorescence microscopy was used to study the interactions of TGRPs (25- to 35-nm diameter) in the arterial wall. Carotid arteries were harvested from rats, placed in a perfusion chamber, and perfused with fluorescently labeled TGRPs. In the absence of apoE or LpL, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine-TGRP (100 µg neutral lipid/mL) was poorly retained in the arterial wall. The addition of either apoE (10 µg/mL) or LpL (10 µg/mL) increased TGRP accumulation 220% and 100%, respectively. This effect was attenuated by heparin (10.0 IU/mL). Histological analyses of cross sections from these vessels demonstrate that in the absence of apoE or LpL, there is deep penetration of lipid into the arterial wall. With the addition of either apoE or LpL, arterial wall penetration of TGRP is blocked.
Conclusions These results demonstrate that although apoE and LpL increase arterial wall accumulation of TGRPs, these proteins also reduce the penetration of TGRPs into the arterial wall. We postulate that this may represent a novel antiatherogenic property of apoE and LpL.
Key Words: apolipoprotein E lipoprotein lipase quantitative fluorescence microscopy arterial wall atherosclerosis
This article has been cited by other articles:
![]() |
A. Wehinger, I. Tancevski, W. Schgoer, P. Eller, K. Hochegger, M. Morak, A. Hermetter, A. Ritsch, J. R. Patsch, and B. Foeger Phospholipid Transfer Protein Augments Apoptosis in THP-1-Derived Macrophages Induced by Lipolyzed Hypertriglyceridemic Plasma Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 908 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Mullick, A. F. Powers, R. S. Kota, S. D. Tetali, J. P. Eiserich, and J. C. Rutledge Apolipoprotein E3- and Nitric Oxide-Dependent Modulation of Endothelial Cell Inflammatory Responses Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 339 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Mullick, U. B. Zaid, C. N. Athanassious, S. R. Lentz, J. C. Rutledge, and J. D. Symons Hyperhomocysteinemia increases arterial permeability and stiffness in mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1349 - R1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Tetali, M. S. Budamagunta, J. C. Voss, and J. C. Rutledge C-terminal interactions of apolipoprotein E4 respond to the postprandial state J. Lipid Res., July 1, 2006; 47(7): 1358 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Symons, U. B. Zaid, C. N. Athanassious, A. E. Mullick, S. R. Lentz, and J. C. Rutledge Influence of Folate on Arterial Permeability and Stiffness in the Absence or Presence of Hyperhomocysteinemia Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 814 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Proctor, D. F. Vine, and J. C.L. Mamo Arterial Permeability and Efflux of Apolipoprotein B-Containing Lipoproteins Assessed by In Situ Perfusion and Three-Dimensional Quantitative Confocal Microscopy Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2162 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Verseyden, S. Meijssen, and M. C. Cabezas Effects of Atorvastatin on Fasting Plasma and Marginated Apolipoproteins B48 and B100 in Large, Triglyceride-Rich Lipoproteins in Familial Combined Hyperlipidemia J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5021 - 5029. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Weinberg, C. Paisanthasan, D. Feinstein, and W. Hoffman The Effect of Bupivacaine on Myocardial Tissue Hypoxia and Acidosis During Ventricular Fibrillation Anesth. Analg., March 1, 2004; 98(3): 790 - 795. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |